Open AccessSTATINS, BUT NOT PCSK9 INHIBITORS, REDUCE THE ADIPOKINE CHEMERIN IN FAMILIAL HYPERCHOLESTEROLEMIA: FOCUS ON LIPOPROTEIN SUBFRACTIONS
Author(s) -
Liwen Tan,
Na Wang,
Leonie Van Vark Van Der Zee,
Jeanine Roeters van Lennep,
Monique Mulder,
Xinzheng Lu,
A.H. Jan Danser,
Koen Verdonk
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000838636.80490.4d
Subject(s) - chemerin , medicine , endocrinology , fluvastatin , dyslipidemia , adipokine , triglyceride , cholesterol , lipoprotein , rosuvastatin , statin , simvastatin , diabetes mellitus , insulin resistance